Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N H Mulder

Showing results (191-200 of 369) with videos related to

Pageof 37
Sort By:
International Journal of Cancer|July 15, 1990
A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistanceG A Hospers, C Meijer, L de Leij, et al.
Anti-Cancer Drugs|February 1, 1993
A phase I study of lobaplatin (D-19466) administered by 72 h continuous infusionJ A Gietema, H J Guchelaar, E G de Vries, et al.
Cancer Treatment Reports|May 1, 1986
High-dose teniposide for refractory malignancies: a phase I studyE G de Vries, N H Mulder, P E Postmus, et al.
European Journal of Nuclear Medicine|January 1, 1985
Spermidine level as a parameter in the treatment of patients with malignant melanomaJ M Smit, H Jurjens, J Bouman, et al.
Journal of Hematotherapy|October 1, 1995
Bispecific monoclonal antibodies for intravenous treatment of carcinoma patients: immunobiologic aspectsB J Kroesen, R A Janssen, J Buter, et al.
Blut|October 1, 1983
Autologous cryopreserved platelets and prophylaxis of bleeding in autologous bone marrow transplantationG W van Imhoff, F Arnaud, P E Postmus, et al.
Oncology|January 1, 1983
Effect of chemotherapy on taste sensation in patients with disseminated malignant melanomaN H Mulder, J M Smit, W M Kreumer, et al.
Cancer Research|August 15, 1989
High-dose cyclophosphamide or melphalan with escalating doses of mitoxantrone and autologous bone marrow transplantation for refractory solid tumorsP O Mulder, D T Sleijfer, P H Willemse, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1989
Phase II study of bleomycin, dacarbazine (DTIC) and vindesine in disseminated malignant melanomaN H Mulder, D T Sleijfer, E G de Vries, et al.
Gynecologic Oncology|March 1, 1984
Effective high-dose chemotherapy with autologous bone marrow infusion in resistant ovarian cancerR Vriesendorp, J G Aalders, D T Sleijfer, et al.
Pageof 37

Showing results (191-200 of 369) with videos related to

Sort By:
Pageof 37
International Journal of Cancer|July 15, 1990
A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistanceG A Hospers, C Meijer, L de Leij, et al.
Anti-Cancer Drugs|February 1, 1993
A phase I study of lobaplatin (D-19466) administered by 72 h continuous infusionJ A Gietema, H J Guchelaar, E G de Vries, et al.
Cancer Treatment Reports|May 1, 1986
High-dose teniposide for refractory malignancies: a phase I studyE G de Vries, N H Mulder, P E Postmus, et al.
European Journal of Nuclear Medicine|January 1, 1985
Spermidine level as a parameter in the treatment of patients with malignant melanomaJ M Smit, H Jurjens, J Bouman, et al.
Journal of Hematotherapy|October 1, 1995
Bispecific monoclonal antibodies for intravenous treatment of carcinoma patients: immunobiologic aspectsB J Kroesen, R A Janssen, J Buter, et al.
Blut|October 1, 1983
Autologous cryopreserved platelets and prophylaxis of bleeding in autologous bone marrow transplantationG W van Imhoff, F Arnaud, P E Postmus, et al.
Oncology|January 1, 1983
Effect of chemotherapy on taste sensation in patients with disseminated malignant melanomaN H Mulder, J M Smit, W M Kreumer, et al.
Cancer Research|August 15, 1989
High-dose cyclophosphamide or melphalan with escalating doses of mitoxantrone and autologous bone marrow transplantation for refractory solid tumorsP O Mulder, D T Sleijfer, P H Willemse, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1989
Phase II study of bleomycin, dacarbazine (DTIC) and vindesine in disseminated malignant melanomaN H Mulder, D T Sleijfer, E G de Vries, et al.
Gynecologic Oncology|March 1, 1984
Effective high-dose chemotherapy with autologous bone marrow infusion in resistant ovarian cancerR Vriesendorp, J G Aalders, D T Sleijfer, et al.
Pageof 37